Association of an HLA-DQ allele with clinical tuberculosis

JAMA

Volumn 279, Issue 3, 1998, Pages 226-228

  Goldfeld, Anne E ^a   Delgado, Julio C ^a   Thim, Sok ^b   Bozon, M Viviana ^a   Uglialoro, Adele M ^a   Turbay, David ^a   Cohen, Carol ^a   Yunis, Edmond J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Cambodian Health Committee   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOSIS;

EID: 0032554132     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.3.226     Document Type: Article

References (36)

1. World Health Organization (WHO) Report on the TB Epidemic. Geneva, Switzerland: WHO; 1994.
2. Porter JDH, McAdam KPWJ. The re-emergence of tuberculosis. Annu Rev Public Health. 1994;15:303-323.
3. Bloom BR, Murray CWL. Tuberculosis: commentary on a reemergent killer. Science. 1992;257:1055-1064.
4. Rom W, Garay S. Tuberculosis. Boston, Mass: Little Brown Inc; 1996.
5. Bloom BR. Tuberculosis: Pathogenesis, Protection and Control. Washington, DC: American Society for Microbiology; 1994.
6. Conn DL, Dobkin JF. Treatment and prevention of tuberculosis in HIV infection. AIDS. 1993;7(1, suppl):S195-S202.
7. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Am Rev Respir Dis. 1991;144:745-749.
8. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and 'compliance' lessons from rural Haiti. Semin Respir Infect. 1991;6:254-260.
9. Skamene E. The BCG gene story. Immunobiology. 1994;191:451-460.
10. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med. 1990;322:422-427.
11. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, et al. Association of pulmonary tuberculosis and HLA in South India. Tubercle. 1991;72:123-132.
12. Bothamley GH, Beck JS, Schreuder GMT, et al. Association of tuberculosis and M tuberculosis-specific antibody levels with HLA. J Infect Dis. 1989;159:549-555.
13. Khomenko AG, Litvinov VI, Chukanova VP, Pospelov LE. Tuberculosis in patients with various HLA phenotypes. Tubercle. 1990;71:187-192.
14. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941-1949.
15. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996;335:1956-1961.
16. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995;2:561-572.
17. Rook GAW. Mycobacteria, cytokines and antibiotics. Pathol Biol. 1990;38:276-280.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988;16:1215.
19. Cereb N, Maye P, Lee S, Kong Y, Yang SY. Locus specific amplification of HLA class I genes from genomic DNA. Tissue Antigens. 1995;45:1-11.
20. Bozon MV, Delgado JC, Turbay D, et al. Comparison of HLA-A antigen typing by serology with two polymerase chain reaction based DNA typing methods. Tissue Antigens. 1996;47:512-518.
21. Yunis JJ, Delgado MB, Lee-Lewandroski E, Yunis EJ, Bing DH. Rapid identification of HLA-DRw53-positive samples by a generic DRB-PCR amplification without further analysis. Tissue Antigens. 1992;40:41-44.
22. Kimura A, Sasazuki T. Eleventh International Histocompatibilty Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. New York, NY: Oxford University Press Inc; 1992:397-419.
23. Salazar M, Yunis JJ, Delgado MB, Bing D, Yunis EJ. HLA-DQB1 allele typing by a new PCR-RFLP method. Tissue Antigens. 1992;40:116-123.
24. Yunis JJ, Salazar M, Delgado MB, Alper CA, Bing DH, Yunis EJ. HLA-DQA1, DQB1 and DPB alleles on HLA-DQ2-and DQ9-carrying extended haplo-types. Tissue Antigens. 1993;41:37-41.
25. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclatures for factors of the HLA system, 1995. Tissue Antigens. 1995:46:1-18.
26. Wilson AG, Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177:557-560.
27. Congressional Hunger Caucus Round Table Hearing on Tuberculosis Emergency (statement of Anne E. Goldfeld, MD, February 10, 1994).
28. Rith DN. Tuberculosis in Cambodia. In: Proceedings From the Congress for Anti-Tuberculosis Activities Throughout Cambodia. Phnom Penh: Cambodian Ministry of Health; 1996.
29. Miles SH, Maat RB. A successful supervised out-patient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border. Am Rev Respir Dis. 1984;130:827-830.
30. United Nations Children's Fund. Cambodia: The Situation of Women and Children. Phnom Penh, Cambodia: Office of the Special Representative, United Nations Children's Fund; 1990.
31. d'Cruz-Grote D. Prevention of HIV infection in developing countries. Lancet. 1996;348:1071-1074.
32. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the TNF-α -308 promoter polymorphism in TNF-α gene regulation. J Inflamm. 1996;46:32-39.
33. Opelz G, Mytilineos J, Scherer S, et al. Survival of DNA HLA-DR types and matched cadaver kidney transplant. Lancet. 1991;338:461-463.
34. Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN. Polymerase chain reaction-based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis. J Infect Dis. 1996;173:669-676.
35. Brown JH, Jardetsky TS, Gorga JC, et al. Three dimensional structure of the human class 11 histocompatibility antigen HLA-DR1. Nature. 1993;364:33-39.
36. Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368:215-221.